Gesynta Pharma Receives $27 Million For Endometriosis Novel Therapy Drug
Swedish biotech company Gesynta Pharma AB has secured $27 million in a Series B financing round led by Innovestor Life Science in Finland.
Ely Echo13h
Letter to the editor
The Ely Echo weekly newspaper and its companion pieces - North Country SAVER and North Country ANGLER - provide insight into ...
U of M offered $600 million to re-acquire University of Minnesota Medical Center
Minneapolis-based health system said the sum wouldn’t cover debts; the U then developed proposal with Essentia Health.